B vs BHP
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The Advanced Deterministic Scorecard reveals a mixed financial profile: the Piotroski F-Score of 4/9 indicates borderline financial health, while the absence of an Altman Z-Score prevents a full distress risk assessment. Despite strong profitability and growth metrics—evidenced by 23.2% YoY revenue growth and 175.7% earnings growth—the stock trades above its Graham Number of $26.91 at $51.08, reflecting rich valuation. Solid balance sheet metrics like a 0.14 Debt/Equity ratio and 2.94 Current Ratio support resilience, but weak technical trend (10/100) and inconsistent analyst targets temper bullishness. The stock's premium valuation appears justified by strong historical performance and sector outperformance, yet sustainability depends on maintaining high growth and disciplined capital allocation.
BHP's Piotroski F-Score of 6/9 indicates stable financial health, but the absence of an Altman Z-Score limits distress risk assessment. The stock trades significantly above its Graham Number of $27.35 and intrinsic value of $24.78, reflecting a substantial premium. Despite strong profitability metrics like 37.7% operating margin and 21.99% ROE, earnings and revenue growth are sharply negative year-over-year. Analysts consensus is a hold with a $57.00 target, below current price, suggesting limited upside.
Compare Another Pair
B vs BHP: Head-to-Head Comparison
This page compares Barrick Mining Corporation (B) and BHP Group Limited (BHP) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.